Supplementary Methods 1 from &lt;i&gt;RAS/RAF&lt;/i&gt; Comutation and &lt;i&gt;ERBB2&lt;/i&gt; Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer